The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization.

MLA

Orlandi, A., et al. “The Recombinant Major Allergen of Parietaria Judaica and Its Hypoallergenic Variant: In Vivo Evaluation in a Murine Model of Allergic Sensitization.” Clinical & Experimental Allergy, vol. 34, no. 3, Mar. 2004, pp. 470–77. EBSCOhost, https://doi.org/10.1111/j.1365-2222.2004.01894.x.

APA

Orlandi, A., Grasso, F., Corinti, S., Marinaro, M., Bonura, A., Boirivant, M., Colombo, P., & Di Felice, G. (2004). The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization. Clinical & Experimental Allergy, 34(3), 470–477. https://doi.org/10.1111/j.1365-2222.2004.01894.x

Chicago

Orlandi, A., F. Grasso, S. Corinti, M. Marinaro, A. Bonura, M. Boirivant, P. Colombo, and G. Di Felice. 2004. “The Recombinant Major Allergen of Parietaria Judaica and Its Hypoallergenic Variant: In Vivo Evaluation in a Murine Model of Allergic Sensitization.” Clinical & Experimental Allergy 34 (3): 470–77. doi:10.1111/j.1365-2222.2004.01894.x.